SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-023801
Filing Date
2017-11-14
Accepted
2017-11-14 16:48:18
Documents
60
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bold-10q_20170930.htm 10-Q 1814200
2 EX-31.1 bold-ex311_6.htm EX-31.1 7885
3 EX-31.2 bold-ex312_11.htm EX-31.2 7878
4 EX-32.1 bold-ex321_10.htm EX-32.1 6343
5 EX-32.2 bold-ex322_9.htm EX-32.2 6303
  Complete submission text file 0001564590-17-023801.txt   6438492

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bold-20170930.xml EX-101.INS 1510241
7 XBRL TAXONOMY EXTENSION SCHEMA bold-20170930.xsd EX-101.SCH 42395
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bold-20170930_cal.xml EX-101.CAL 40706
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bold-20170930_def.xml EX-101.DEF 127874
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bold-20170930_lab.xml EX-101.LAB 329475
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bold-20170930_pre.xml EX-101.PRE 257032
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37833 | Film No.: 171202414
SIC: 2836 Biological Products, (No Diagnostic Substances)